Ed Markey @SenMarkey
First, we won a Medicare cap on insulin co-pays in the IRA. Then, Eli Lilly announced a cost cap on insulin. Now, Novo Nordisk is cutting prices by up to 75%. The pressure is working. But we can't leave it up to Big Pharma—Congress must go further. — PolitiTweet.org
The Wall Street Journal @WSJ
Breaking: Novo Nordisk, a large insulin maker, plans to cut the prices of its widely used products up to 75% to mak… https://t.co/wVkSopIx06